零麻风病战略计划:全球和国家层面:简短交流

K. Geetha
{"title":"零麻风病战略计划:全球和国家层面:简短交流","authors":"K. Geetha","doi":"10.4103/cdr.cdr_118_23","DOIUrl":null,"url":null,"abstract":"Since the launch of multidrug therapy in 1982, the global leprosy situation has undergone significant changes, with the prevalence falling from over 5 million cases in the mid-1980s to <200,000 by the end of 2016. In India, the program reduced the prevalence rate from 57.8/10,000 in 1983 to <1/10,000 by the end of 2005, marking the achievement of the World Health Organizations (WHOs) target of eliminating leprosy as a public health issue. The WHO has recently introduced a new global leprosy plan called “Towards Zero Leprosy” as part of the disease-specific strategies outlined in the WHO's roadmap for neglected tropical diseases (NTDs) 2021–2030. This strategy aims to achieve interruption of leprosy transmission by 2030 and provides a framework for direction, objectives, challenges, and strategic pillars at a global level. In India, a committee of over 80 experts in the field of leprosy developed the National Strategic Plan and Roadmap for Leprosy 2023–2027, which was published on January 30, 2023. This policy is aligned with the WHO's NTDs roadmap 2021–2030 and the Global Leprosy Strategy 2021–2030, both of which aim to interrupt leprosy transmission by 2030. In this article, we have discussed the strategic plans of both the National leprosy eradication programme (NLEP) and the WHO.","PeriodicalId":34880,"journal":{"name":"Clinical Dermatology Review","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Zero Leprosy Strategic Plans: Global and National Level: A Short Communication\",\"authors\":\"K. Geetha\",\"doi\":\"10.4103/cdr.cdr_118_23\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Since the launch of multidrug therapy in 1982, the global leprosy situation has undergone significant changes, with the prevalence falling from over 5 million cases in the mid-1980s to <200,000 by the end of 2016. In India, the program reduced the prevalence rate from 57.8/10,000 in 1983 to <1/10,000 by the end of 2005, marking the achievement of the World Health Organizations (WHOs) target of eliminating leprosy as a public health issue. The WHO has recently introduced a new global leprosy plan called “Towards Zero Leprosy” as part of the disease-specific strategies outlined in the WHO's roadmap for neglected tropical diseases (NTDs) 2021–2030. This strategy aims to achieve interruption of leprosy transmission by 2030 and provides a framework for direction, objectives, challenges, and strategic pillars at a global level. In India, a committee of over 80 experts in the field of leprosy developed the National Strategic Plan and Roadmap for Leprosy 2023–2027, which was published on January 30, 2023. This policy is aligned with the WHO's NTDs roadmap 2021–2030 and the Global Leprosy Strategy 2021–2030, both of which aim to interrupt leprosy transmission by 2030. In this article, we have discussed the strategic plans of both the National leprosy eradication programme (NLEP) and the WHO.\",\"PeriodicalId\":34880,\"journal\":{\"name\":\"Clinical Dermatology Review\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Dermatology Review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/cdr.cdr_118_23\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Dermatology Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/cdr.cdr_118_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

自1982年启动多种药物疗法以来,全球麻风病形势发生了重大变化,患病率从20世纪80年代中期的500多万例下降到2016年底的小于20万例。在印度,该计划将麻风病患病率从1983年的57.8/10,000降至2005年底的<1/10,000,标志着世界卫生组织(WHO)实现了消除麻风病这一公共卫生问题的目标。世卫组织最近推出了一项名为 "实现零麻风病 "的新全球麻风病计划,作为世卫组织 2021-2030 年被忽视热带疾病(NTDs)路线图中概述的特定疾病战略的一部分。该战略旨在到 2030 年实现阻断麻风病的传播,并为全球层面的方向、目标、挑战和战略支柱提供了一个框架。在印度,一个由 80 多名麻风病领域专家组成的委员会制定了《2023-2027 年麻风病国家战略计划和路线图》,并于 2023 年 1 月 30 日发布。这项政策与世界卫生组织的《2021-2030 年非传染性疾病路线图》和《2021-2030 年全球麻风病战略》相一致,这两项战略的目标都是到 2030 年阻断麻风病的传播。在本文中,我们讨论了国家根除麻风病计划(NLEP)和世界卫生组织的战略计划。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Zero Leprosy Strategic Plans: Global and National Level: A Short Communication
Since the launch of multidrug therapy in 1982, the global leprosy situation has undergone significant changes, with the prevalence falling from over 5 million cases in the mid-1980s to <200,000 by the end of 2016. In India, the program reduced the prevalence rate from 57.8/10,000 in 1983 to <1/10,000 by the end of 2005, marking the achievement of the World Health Organizations (WHOs) target of eliminating leprosy as a public health issue. The WHO has recently introduced a new global leprosy plan called “Towards Zero Leprosy” as part of the disease-specific strategies outlined in the WHO's roadmap for neglected tropical diseases (NTDs) 2021–2030. This strategy aims to achieve interruption of leprosy transmission by 2030 and provides a framework for direction, objectives, challenges, and strategic pillars at a global level. In India, a committee of over 80 experts in the field of leprosy developed the National Strategic Plan and Roadmap for Leprosy 2023–2027, which was published on January 30, 2023. This policy is aligned with the WHO's NTDs roadmap 2021–2030 and the Global Leprosy Strategy 2021–2030, both of which aim to interrupt leprosy transmission by 2030. In this article, we have discussed the strategic plans of both the National leprosy eradication programme (NLEP) and the WHO.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
45 weeks
期刊最新文献
Pulse Therapy in Rituximab Era: A Retrospective Study of 124 Patients of Pemphigus from a Tertiary Care Center of South Rajasthan A Baby with Café-au-lait Macules and Aberrant Mongolian Spot: Report of Phakomatosis Pigmentopigmentaria Reactive Infectious Mucocutaneous Eruption with Extensive Cutaneous Involvement Orofacial Granulomatosis Secondary to Cutaneous Tuberculosis: An Atypical Presentation Mucocutaneous Manifestations among Patients with Malignancies at a Tertiary Care Center in Maharashtra: A Cross-Sectional Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1